Computer-Aided Learning for Managing Stress (CALMS)

February 22, 2018 updated by: Kristen Woodberry, Beth Israel Deaconess Medical Center

A Pilot Study of Computerized Biofeedback Games With Young People Experiencing Psychotic-Spectrum Symptoms

The purpose of this study is to learn whether a new family therapy using computer games with biofeedback might help people at clinical high risk for psychosis and their family members learn to experience less stress and have fewer mental health challenges.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

CALMS revolves around the use of Emotional Manipulatives (EM) developed at Boston Children's Hospital (BCH). EM are single and multi-user biofeedback games designed to enhance executive control of emotion. The intervention and EM in CALMS were adapted from those used in Anger Control Training (ACT) with Regulate and Gain Emotional Control (RAGE-Control). In a randomized controlled trial at BCH, ACT and RAGE-Control relative to "sham" video-game play without biofeedback led to significantly greater reductions of aggression in adolescents and greater improvement in family functioning.

In this feasibility study, family dyads will participate in 12 sessions aimed at

  1. enhancing engagement through the use of video and other games,
  2. enhancing stress resilience through biofeedback, education, and individualized stress-reduction practice, and
  3. harnessing the power of the family to enhance contextual learning and the generality and duration of effects.

Clinical, self-report, and heart rate measures will be assessed at baseline, 4, 8, and 12 week assessments.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Beth Israel Deaconess Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 30 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Currently Meet or Have Met Criteria of Prodromal Syndromes (COPS) according to the SIPS within the past 2 years
  • Estimated IQ > 70
  • Speak fluent English
  • Have at least one parent or adult family member who also speaks fluent English and is willing to participate

Exclusion Criteria:

  • Physical limitations precluding effective use of biofeedback videogames
  • Co-morbid psychiatric disorders, including substance disorders, but only if they better explain COPS symptoms or make participation counter-indicated.
  • Active suicidal ideation or attempts within the past 2 months unless being actively monitored and treated for this by a clinician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CALMS
12 session family therapy using multi-user biofeedback games
Family Therapy; Multi-user Biofeedback Videogames

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility: Percent of referred who consent and meet study criteria
Time Frame: Up to six months
Enrollment
Up to six months
Feasibility: Percent of 12 sessions completed
Time Frame: Up to six months
Engagement: Percent of sessions completed by consented and eligible participants
Up to six months
Feasibility: Counts of premature termination of intervention
Time Frame: Up to six months
Up to six months
Feasibility: Self-report of Credibility/Satisfaction
Time Frame: 12 week assessment or last assessment completed
Individual and family member self-report
12 week assessment or last assessment completed
Feasibility: Self-report of User Experience
Time Frame: 12 week assessment or last assessment completed
Self-report of ability to learn/use technology to lower stress reactivity
12 week assessment or last assessment completed

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Perceived Stress relative to Baseline
Time Frame: Weeks 4, 8, and 12 Assessments
Self-report via Perceived Stress Scale
Weeks 4, 8, and 12 Assessments
Change relative to Baseline in Youth Perceptions of Relationship with Family Member
Time Frame: Weeks 4, 8, 12 Assessments
Self-report of conflict, criticism, and warmth in relationship with participating family member
Weeks 4, 8, 12 Assessments
Change relative to Baseline in Parent Perceptions of Relationship with Adolescent or Young Adult
Time Frame: Weeks 4, 8, 12 Assessments
Self-report of conflict, criticism, and warmth in relationship with youth
Weeks 4, 8, 12 Assessments
Positive Symptom Score Change relative to Baseline
Time Frame: Weeks 4,8, and 12 Assessments
Total positive symptom score according to the Structured Interview of Psychosis-risk Syndromes (SIPS)
Weeks 4,8, and 12 Assessments
Change in Social and Role Functioning relative to Baseline
Time Frame: Weeks 4, 8, and 12 Assessments
Global Functioning: Social & Role Scales;
Weeks 4, 8, and 12 Assessments
Change in Global Functioning relative to Baseline
Time Frame: Weeks 4, 8, and 12 Assessments
SIPS Global Assessment of Functioning
Weeks 4, 8, and 12 Assessments
Safety: Change in Hostility/Aggression relative to Baseline
Time Frame: Weeks 4, 8, and 12
Self-report
Weeks 4, 8, and 12
Safety: Change in Video-game Addiction relative to Baseline
Time Frame: Weeks 4, 8, and 12
Self-report
Weeks 4, 8, and 12
Difference in reaction times for emotional and calm faces on an Emotional Go/NoGo Task
Time Frame: Baseline, Weeks 4,8, and 12
Executive Control of Emotion
Baseline, Weeks 4,8, and 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristen Woodberry, MSW, Ph.D., Beth Israel Deaconess Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

January 5, 2018

Study Completion (Actual)

January 5, 2018

Study Registration Dates

First Submitted

July 13, 2015

First Submitted That Met QC Criteria

August 21, 2015

First Posted (Estimate)

August 24, 2015

Study Record Updates

Last Update Posted (Actual)

February 23, 2018

Last Update Submitted That Met QC Criteria

February 22, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2012P000377
  • K23MH102358 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychosis

3
Subscribe